Impact of ibuprofen administration on renal drug clearance in the first weeks of life

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 8, 2006, Pages 519-522

  Allegaert, K ^a   Rayyan, M ^a   Anderson, B J ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Amikacin; Ibuprofen; Nonlinear mixed effects population pharmacokinetics; Preterm infants; Renal function; Vancomycin

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; BETAMETHASONE; DOPAMINE; IBUPROFEN; INDOMETACIN; VANCOMYCIN;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG CLEARANCE; HUMAN; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PROPHYLAXIS;

AGE FACTORS; AMIKACIN; ANTI-BACTERIAL AGENTS; ASPIRIN; BETAMETHASONE; BIRTH WEIGHT; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DUCTUS ARTERIOSUS, PATENT; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; KIDNEY; METABOLIC CLEARANCE RATE; POSTMENOPAUSE; PREGNANCY; TIME FACTORS; VANCOMYCIN;

EID: 33845363706     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.8.1037489     Document Type: Article

References (21)

1. Guignard, J.P. The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit. Semin Perinatol 2002, 26: 398-405.
2. van den anker, J.N. Pharmacokinetics and renal function in preterm infants. Acta Paediatr 1996, 85: 1393-9.
3. Van Overmeire, B., Allegaert, K., Casaer, A. et al. Prophylactic ibuprofen in premature infants: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004, 364(9449): 1945-9.
4. Van Overmeire, B., Smets, K., Lecoutere, D. et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000, 343: 674-81.
5. Allegaert, K., Anderson, B. Antenatal steroids and neonatal renal function. Arch Dis Child 2006, 91: 451.
6. de Hoog, M., van den Anker, J.N. Aminoglycosides and glycopeptides. In: Neonatal and Pediatric Pharmacology, 3rd ed. Yaffe, S., Aranda, J.V. (Eds.). Lippincott Williams and Wilkins: Philadelphia 2005, 377-401.
7. de Hoog, M., Mouton, J.W., van den Anker, J.N. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med 2005, 10: 185-94.
8. Koren, G., James, A., Perlman, M. A simple method for the estimation of glomerular filtration rate by gentamycin pharmacokinetics during routine drug monitoring in the newborn. Clin Pharmacol Ther 1985, 38: 680-5.
9. Allegaert, K., Vanhole, C., de Hoon, J. et al. Non-selective cyclooxygenase inhibitors and glomerular filtration rate in preterm neonates. Pediatr Nephrol 2005, 20: 1557-61.
10. Allegaert, K., Cossey, V., Langhendries, J.P. et al. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of Amikacin in preterm infants during the first days of life. Biol Neonate 2004, 86: 207-11.
11. Seay, R.E., Brundage, R.C., Jensen, P.D., Schilling, C.G., Edgren, B.E. Population pharmacokinetics of vancomycin in neonates. Clin Pharmacol Ther 1994, 56: 169-75.
12. Capparelli, E.V., Lane, J.R., Romanowski, G.L. et al. The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol 2001, 41: 927-34.
13. Anderson, B.J., Allegaert, K., Holford, N.H. Population clinical pharmacology of children: Modelling covariate effects. Eur J Pediatr 2006, (available online).
14. Allegaert, K., Anderson, B.J., Cossey, V., Holford, N.H. Limited predictability of amikacin clearance in extreme premature neonates at birth. Br J Clin Pharmacol 2006, 61: 39-48.
15. Anderson, B.J., Allegaert, K., van den anker, J.N., Cossey, V., Holford, N.H. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 2006, (available online).
16. Sheiner, L.B., Beal, S.L. NONMEM Users Guide. Division of Pharmacology, University of California: San Francisco 1979.
17. Anderson, B.J., Meakin, G.H. Scaling for size: Some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002, 12: 205-19.
18. Holford, N.H. A size standard for pharmacokinetics. Clin Pharmacokinet 1996, 30: 329-32.
19. West, G.B., Brown, J.H., Enquist, B.J. A general model for the origin of allometric scaling laws in biology. Science 1997, 276: 122-6.
20. Vinks, A.A. The application of population pharmacokinetic modelling to individualized antibiotic therapy. Int J Antimicrob Agents 2002, 19: 313-22.
21. van den anker, J.N. Managing drugs safely. Semin Fetal Neonatal Med 2005, 10: 73-81.